These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3551819)

  • 21. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
    MacCallum DM; Castillo L; Brown AJ; Gow NA; Odds FC
    PLoS One; 2009 Jul; 4(7):e6420. PubMed ID: 19641609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models of candidiasis.
    Clancy CJ; Cheng S; Nguyen MH
    Methods Mol Biol; 2009; 499():65-76. PubMed ID: 19152040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei.
    Koga-Ito CY; Komiyama EY; Martins CA; Vasconcellos TC; Jorge AO; Carvalho YR; do Prado RF; Balducci I
    Mycoses; 2011 Sep; 54(5):e278-85. PubMed ID: 20492535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis.
    Martins M; Lazzell AL; Lopez-Ribot JL; Henriques M; Oliveira R
    J Basic Microbiol; 2012 Aug; 52(4):487-91. PubMed ID: 22052380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
    Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
    Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
    Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
    Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathomorphology of experimental candidiasis in mice treated with sodium salt of an N-succinyl derivative of perimycin].
    Hrabowska M
    Acta Biol Med (Gdansk); 1969; 14(3):227-53. PubMed ID: 5396660
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergistic infection with murine cytomegalovirus and Candida albicans in mice.
    Hamilton JR; Overall JC; Glasgow LA
    J Infect Dis; 1977 Jun; 135(6):918-24. PubMed ID: 193998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental hematogenous endophthalmitis caused by Candida albicans.
    Edwards JE; Montgomerie JZ; Foos RY; Shaw VK; Guze LB
    J Infect Dis; 1975 Jun; 131(6):649-57. PubMed ID: 48529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil activation by Candida glabrata but not Candida albicans promotes fungal uptake by monocytes.
    Duggan S; Essig F; Hünniger K; Mokhtari Z; Bauer L; Lehnert T; Brandes S; Häder A; Jacobsen ID; Martin R; Figge MT; Kurzai O
    Cell Microbiol; 2015 Sep; 17(9):1259-76. PubMed ID: 25850517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathology of experimental systemic candidosis in guinea-pigs.
    Fransen J; Van Cutsem J; Vandesteene R; Janssen PA
    Sabouraudia; 1984; 22(6):455-69. PubMed ID: 6395373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in virulence between two Candida albicans strains in experimental keratitis.
    O'Day DM; Head WS; Csank C; Shetlar DJ; Robinson RD; McCollum GW; Yang R; Zhu TL; Wang MX
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1116-21. PubMed ID: 10752949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative virulence of Candida albicans strains in CFW1 mice and Sprague-Dawley rats.
    Schmidt A; Geschke U
    Mycoses; 1996; 39(5-6):157-60. PubMed ID: 8909024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
    Shepherd MG
    Infect Immun; 1985 Nov; 50(2):541-4. PubMed ID: 3902649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence of South African Candida albicans strains isolated from different clinical samples.
    Ells R; Kilian W; Hugo A; Albertyn J; Kock JL; Pohl CH
    Med Mycol; 2014 Apr; 52(3):246-53. PubMed ID: 24577008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility.
    Fulurija A; Ashman RB; Papadimitriou JM
    J Med Vet Mycol; 1997; 35(3):197-203. PubMed ID: 9229336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis.
    Chiang LY; Sheppard DC; Bruno VM; Mitchell AP; Edwards JE; Filler SG
    Cell Microbiol; 2007 Jan; 9(1):233-45. PubMed ID: 16939537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans Sfl2, a temperature-induced transcriptional regulator, is required for virulence in a murine gastrointestinal infection model.
    Song W; Wang H; Chen J
    FEMS Yeast Res; 2011 Mar; 11(2):209-22. PubMed ID: 21205158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Candidal carriage and the development of invasive candidiasis of the organs of the digestive tract during experimental immunodepression].
    Pakhomova EN; Bykov VL; Karaev EO
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):7-10. PubMed ID: 2220223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.